Skip to main content

Stephen Mora

Institutions of which they are part

Neurodegenerative Diseases
Vall Hebron Institut de Recerca
Stephen  Mora

Stephen Mora

Stephen  Mora

Institutions of which they are part

Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Related news

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

This initiative is part of a pioneering study that seeks to assess how the relationship between different age groups can influence the quality of life and mental health of patients.

Related professionals

Maria Antonia Ramon Belmonte

Maria Antonia Ramon Belmonte

Senior researcher
Pneumology
Read more
Ana  Román Mora

Ana Román Mora

Secretary
Communication Unit
Communication Directorate
Read more
Sara Lopez Gonzalez

Sara Lopez Gonzalez

Research technician
Rheumatology
Read more
Silvia Ruiz Álvarez

Silvia Ruiz Álvarez

Administration and Management
Neurovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.